Rocket Pharmaceuticals, Inc. (RCKT)
2.54
-0.04
(-1.55%)
USD |
NASDAQ |
Oct 29, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Max Drawdown (5Y) : 96.46% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.46% |
| August 31, 2026 | 96.46% |
| July 31, 2026 | 96.46% |
| June 30, 2026 | 96.46% |
| May 31, 2026 | 96.46% |
| April 30, 2026 | 96.46% |
| March 31, 2026 | 96.46% |
| February 28, 2026 | 96.46% |
| January 31, 2026 | 96.46% |
| December 31, 2025 | 96.46% |
| November 30, 2025 | 96.46% |
| October 31, 2025 | 96.46% |
| September 30, 2025 | 96.46% |
| August 31, 2025 | 96.46% |
| July 31, 2025 | 96.46% |
| June 30, 2025 | 96.46% |
| May 31, 2025 | 96.46% |
| April 30, 2025 | 92.73% |
| March 31, 2025 | 89.88% |
| February 28, 2025 | 87.92% |
| January 31, 2025 | 87.92% |
| December 31, 2024 | 87.92% |
| November 30, 2024 | 87.92% |
| October 31, 2024 | 87.92% |
| September 30, 2024 | 87.92% |
| Date | Value |
|---|---|
| August 31, 2024 | 87.92% |
| July 31, 2024 | 87.92% |
| June 30, 2024 | 87.92% |
| May 31, 2024 | 87.92% |
| April 30, 2024 | 87.92% |
| March 31, 2024 | 87.92% |
| February 29, 2024 | 87.92% |
| January 31, 2024 | 87.92% |
| December 31, 2023 | 87.92% |
| November 30, 2023 | 87.92% |
| October 31, 2023 | 87.92% |
| September 30, 2023 | 87.92% |
| August 31, 2023 | 87.92% |
| July 31, 2023 | 87.92% |
| June 30, 2023 | 87.92% |
| May 31, 2023 | 87.92% |
| April 30, 2023 | 87.92% |
| March 31, 2023 | 87.92% |
| February 28, 2023 | 87.92% |
| January 31, 2023 | 87.92% |
| December 31, 2022 | 87.92% |
| November 30, 2022 | 87.92% |
| October 31, 2022 | 87.92% |
| September 30, 2022 | 89.01% |
| August 31, 2022 | 94.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Sarepta Therapeutics, Inc. | 93.33% |
| Intellia Therapeutics, Inc. | 96.45% |
| Beam Therapeutics, Inc. | 89.12% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.27 |
| Beta (5Y) | 0.4982 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.59% |
| Historical Sharpe Ratio (5Y) | -0.6256 |
| Historical Sortino (5Y) | -1.012 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.11% |